Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer
Year: 2025
Type: erratum
Abstract: A Correction on: Zou L, Chen J, Bai X, Wang Y, Lu C, Wang Q, Tuerhong S, Li M, Zheng Q, Meng F and Du J (2025) Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer. Front. Immunol. 16:1693755. doi: 10.3389/fimmu.2025.1693755 The Editor Christian Klein's affiliation "Ludwig Maximilian University of Munich, Germany" was erroneously given as "Roche Innovation Center Zurich, Switzerland".The original version of this article has been updated.
Source: Frontiers in Immunology
Author: Frontiers Production Office
Institution: Frontiers Media SA (Switzerland)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7115194526
Cites:
Cited by:
Related to: